| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |